Njord Cervical cancer lung metastasis can be controlled with treatment in some cases. The treatment effect depends on the stage of the disease, the scope of metastasis and individual differences.
The therapeutic effect of cervical cancer lung metastasis is closely related to the disease stage. When lung metastases are detected early and are few and limited to one lung lobe, some patients can gain a chance of long-term survival through radical chemoradiotherapy combined with immunotherapy or targeted therapy. The treatment plan is usually based on concurrent radiotherapy and chemotherapy containing platinum drugs, such as cisplatin injection combined with paclitaxel injection, and immunotherapy drugs such as pembrolizumab injection are selected based on genetic testing results.
When lung metastases are multiple or accompanied by other distant metastases, the clinical treatment goal shifts to prolonging survival and improving quality of life. In such cases, palliative care strategies are often used, including comprehensive measures such as analgesic treatment, nutritional support, and psychological intervention. The treatment plan may be bevacizumab injection combined with topotecan capsules for control, and local radiotherapy to relieve symptoms.
Cervical cancer patients should undergo medical evaluation as soon as possible after being diagnosed with lung metastasis, and an oncologist will formulate an individualized treatment plan. During the treatment period, it is necessary to maintain a balanced diet, appropriately supplement high-protein foods and fresh vegetables and fruits, and maintain moderate activity but avoid strenuous exercise. Regularly review and monitor the treatment effect, adjust the treatment plan according to changes in the condition, and pay attention to psychological care and pain management.
